An organized guide to what is actually happening, why it is happening, and what to watch for.

Your skin is changing, and you are trying to figure out whether what you are seeing is normal, worrying, or both.

This post walks through the most common changes chemotherapy causes, organized by what you are likely to notice rather than by the drug category causing it. Under each change, you will find an explanation of what is happening biologically, which categories of chemotherapy are most often responsible, how common the change is in the women who experience it, and what would elevate it from expected to worth mentioning to your oncology team.

A note on how to use this post. Most women on chemotherapy experience several of these at once, to varying degrees of intensity, across the span of treatment. If you are experiencing one of them, scroll to its section. If you are experiencing several, read the sections in any order you like. The post is written to be scanned, not read cover to cover, and nothing in a later section assumes you read the earlier ones.

Before getting into the specific changes, a quick foundation on why any of this happens. The full explanation is in our post on the five types of chemotherapy, but the short version is this: chemotherapy works by targeting rapidly-dividing cells. Cancer cells divide rapidly, which is why the drugs work on them. But your skin's barrier-producing cells, hair follicles, nail matrix cells, and the lining of your gut also divide rapidly, which is why all four of those tissues show predictable side effects. The changes below are not accidents or failures of treatment. They are direct consequences of what the drugs are doing.

Everything that follows is what your oncology team expects to see. Very little of it is cause for alarm. But some of it warrants a phone call, and the sections below will tell you which.

This post is for cancer patients who just want to know what to expect. 

The single most common skin change during chemotherapy, across essentially every drug category, is dryness that is different in kind from any dryness you have experienced before. Not winter-dryness. Not post-flight dryness. A specific, deep, barrier-level dryness that lotion does not fully reach and that returns within an hour of any attempt to address it.

What is happening. Chemotherapy damages the skin's ability to retain water. The stratum corneum — the outermost layer of the skin, made up of tightly-packed cells held together by lipid bilayers — depends on cells that the drugs are disrupting. The result is a barrier that is structurally thinner than it should be, with fewer of the lipids that normally seal in moisture, and cells that are turning over faster than the barrier can replace them. ¹ Water that your skin would normally hold simply leaves, faster than your barrier can prevent.

Which drug categories cause it most. All of them, but some are worse than others. The Bond-Breakers (cyclophosphamide, platinum compounds) are reliably drying. The Sparklers (doxorubicin and the anthracycline family) are among the most drying of the categories. The Scaffold Jammers (taxanes) produce noticeable dryness often accompanied by rash. Antimetabolites vary, with 5-FU and capecitabine being particularly likely to cause significant dryness on the hands and feet.

What to do. The fundamental answer is layered hydration applied to slightly damp skin, reinforced with barrier-supportive ingredients, several times a day. Humectants (hyaluronic acid, glycerin, panthenol) draw water into the skin; emollients (squalane, plant oils, ceramides) help hold it there. Our Deep Hydration Serum is built specifically around four molecular weights of hyaluronic acid, applied to damp skin, and it is one of the two products we recommend most often for cancer patients at any stage of treatment. Our Everyday Hydration Cream is the emollient layer that seals in what the serum has delivered.

When it is worth mentioning. Dryness is almost never an emergency, but if it progresses to visible cracking, bleeding, or a rash you cannot explain, let your oncology team know. The barrier has a threshold beyond which it can no longer self-repair without intervention, and your team can help if you have crossed it.

Chemotherapy makes your skin more sensitive to ingredients, fragrances, and environmental exposures it previously tolerated without issue. Products you used for years can suddenly burn. Fragrances that were pleasant can feel aggressive. This is not your imagination, and it is not a sign that those products were always bad for you. It is a sign that your threshold has changed.

What is happening. A compromised barrier lets more substances penetrate into the deeper layers of the skin, where they can trigger inflammatory or irritant responses they would not have triggered through an intact barrier. At the same time, the chemo-era skin is in a low-grade state of ongoing inflammation, which lowers the threshold for any additional irritant to produce a visible reaction. ²

Which drug categories cause it most. All of them, with taxanes and anthracyclines being particularly associated with reactive skin responses.

What to do. Simplify aggressively. If you have ten products in your routine, trim to four. If you have four, trim to three. Remove anything with added fragrance, essential oils, alcohol denat., and actives like retinol, AHAs, and BHAs. Our foundational post on skincare during cancer treatment walks through the full framework. The short version is: minimal ingredients, barrier-first, nothing ambitious. The Age-Well Routine for Sensitive Skin was built specifically for this kind of reactive state.

When it is worth mentioning. If you develop a reaction to something that was tolerable a week earlier, stop using it and mention it at your next appointment. If you develop a reaction that spreads, includes swelling, or is accompanied by any other symptoms (difficulty breathing, fever), call your oncology team immediately — rarely, chemotherapy can produce allergic reactions to specific drugs that need prompt attention.

A specific kind of pigmentation change during chemotherapy catches many women off guard because it does not match their mental model of what chemo is supposed to do to them. This is not a rash. It is a diffuse darkening of the skin — sometimes patchy, sometimes relatively even, sometimes following sun-exposed areas, sometimes showing up in places that rarely see sunlight. The skin does not hurt and is not itchy. It is just, over the course of a few cycles, a different color than it used to be.

What is happening. Chemotherapy can stimulate melanocytes, the cells that produce melanin (skin pigment), to produce more pigment than they normally would. The mechanism varies by drug but typically involves either direct stimulation of melanocyte activity or accumulation of the drug itself in the skin, where it can either catalyze pigment production or deposit as pigment directly. ³ Busulfan and hydroxyurea can produce diffuse darkening. Cyclophosphamide is specifically associated with hyperpigmentation that can follow nail lunulae, palm creases, or sun-exposed areas. 5-fluorouracil and capecitabine can cause pigment changes that track veins — a distinctive pattern sometimes called "serpentine hyperpigmentation."

Which drug categories cause it most. The Bond-Breakers (especially cyclophosphamide, busulfan), the Counterfeits (especially 5-FU and capecitabine), and bleomycin (grouped with the Sparklers) are the most common sources. Some women call the cyclophosphamide-related diffuse darkening "cyclophosphamide tan," a community term that is not clinical but that captures the experience accurately.

What to do. Sunscreen, consistently and without exception. SPF 30 or higher, mineral (zinc oxide, titanium dioxide) preferred for sensitive skin. Pigment changes triggered by chemotherapy often darken further with sun exposure, and protecting the skin during treatment limits both the intensity and the duration of the change. Beyond sun protection, gentle skincare that does not add insult to already-sensitized skin is the right approach. Do not try to "lighten" pigment changes with brightening actives during active treatment — your skin cannot tolerate hydroquinone, strong AHAs, or many other common brightening ingredients during chemo, and the changes will fade on their own after treatment ends, in a timeline we cover in the companion post on recovery.

When it is worth mentioning. If a pigmentation change is accompanied by pain, swelling, or a distinct border, mention it. If it appears abruptly in a single location rather than developing gradually, mention it. Otherwise, most pigmentation changes during chemo are expected and self-resolving.

Chemotherapy produces several distinct patterns of rash, and the differences between them matter. Most are benign and expected; a few warrant urgent attention.

What is happening. Rashes during chemotherapy fall into several categories. Drug-specific rashes (specific to particular drugs, often appearing within hours to days of infusion), folliculitis-like rashes (especially with targeted therapies grouped alongside chemo), hypersensitivity reactions (allergic responses to specific drugs), and general irritant rashes from a compromised barrier encountering normal ingredients it can no longer tolerate. ⁴

Which drug categories cause it most. Taxanes are the most reliably rash-associated of the traditional chemotherapy categories. Anthracyclines can produce infusion-site reactions specifically. Targeted therapies (technically not chemotherapy but often given alongside it) — HER2-targeted drugs, EGFR inhibitors — are notable for causing specific acneiform rashes that have their own distinct management.

What to do. For mild, diffuse irritation-type rash, simplify your routine to the essentials and let the barrier recover. Our Gentle Cleanser, Deep Hydration Serum, Everyday Hydration Cream are all formulated for gentle skincare, The Dry Rescue Drops is an extra hydrating oil for added support. No actives, no fragrances. For any rash that is spreading rapidly, accompanied by swelling, appearing with fever, or that you feel uncertain about, call your oncology team. They would rather have you call for something that turns out to be nothing than not call for something that turns out to be significant.

When it is worth mentioning. The threshold for mentioning a rash to your oncology team is low. Most rashes during chemo are not emergencies, but your team wants to know about them so they can track patterns and identify any that need active management. A rash accompanied by fever, swelling, trouble breathing, mouth sores, or rapid spreading is a same-day call, not a next-appointment mention. Better safe than sorry. 

Hand-foot syndrome (also called palmar-plantar erythrodysesthesia) is a distinctive and sometimes painful condition specific to a handful of chemotherapy drugs. It is not a generic rash. It is a particular process that affects the palms of the hands and soles of the feet, sometimes the tips of the fingers, with redness, tenderness, peeling, and in more severe cases, blistering. ⁵

What is happening. The drugs responsible for hand-foot syndrome accumulate in the sweat glands concentrated in palms and soles, and the tissue damage from that accumulation produces the characteristic redness, tenderness, and peeling. The symptoms can range from mild (slight redness, mild tenderness) to severe (inability to bear weight, significant peeling, functional impairment).

Which drug categories cause it most. 5-fluorouracil and capecitabine (the Counterfeits) are the most common causes. Liposomal doxorubicin (an anthracycline formulation, grouped with the Sparklers) can also produce it. A few targeted therapies cause a related but distinct syndrome.

What to do. Prevention and management overlap here, and the protocol is unusually specific for a chemotherapy side effect. Keep hands and feet cool during infusion if your oncology team recommends it (some do, some do not — ask). Moisturize intensively and often, throughout the day, including before bed. Avoid friction, hot water, and anything that increases blood flow to the affected areas during active symptoms. Wear comfortable, well-fitting shoes and socks that do not rub. Apply thick emollients — our Dry Rescue Drops or heavy barrier creams — to palms and soles at night. Over-the-counter urea-based creams are sometimes recommended and can be used alongside your Juventude products.

When it is worth mentioning. Always, at every appointment, if you are having any symptoms. Hand-foot syndrome is one of the chemo side effects most responsive to dose modification, and your oncology team needs to know the severity to decide whether dose adjustments are warranted. It is also one of the side effects most worth being proactive about with supportive care, because mild cases can become severe, and severe cases can become reasons to modify or delay treatment. Do not minimize this to your team. Get ahead of it. 

Your skin is more sensitive to ultraviolet light during chemotherapy than it was before treatment. For some drugs, dramatically more sensitive. A sun exposure that would have produced a mild tan before treatment can produce significant reactions during treatment, and those reactions can trigger further pigmentation and rash problems on top of the primary sun damage.

What is happening. Some chemotherapy drugs are direct photosensitizers — they absorb UV energy and produce reactive compounds that damage skin more intensely than UV alone would. Other drugs are indirect photosensitizers, making the skin more reactive to UV through inflammation or barrier compromise. ⁶

Which drug categories cause it most. Methotrexate (Counterfeit), 5-FU (Counterfeit), dacarbazine (Bond-Breaker), vinblastine (Scaffold Jammer), and several others. If you are unsure about your specific regimen, ask your oncology pharmacist — this is exactly the kind of detail she will have.

What to do. Sunscreen, hat, long sleeves, sunglasses. Broad-spectrum mineral SPF 30 or higher, applied every morning and reapplied if you are outside for extended periods. Avoid peak-intensity sun (generally 10 a.m. to 4 p.m.) when possible. This is not the season to try to get a tan, and it is not the season to go to the beach without substantial preparation and protection. Photosensitivity during treatment is one of the strongest reasons to be strict about sun protection, and skin that was protected during chemo recovers better than skin that was not.

When it is worth mentioning. Any significant sunburn during treatment should be reported to your oncology team. Severe reactions to minimal sun exposure are worth mentioning even if they resolve on their own. The team may adjust skincare guidance or flag it as a consideration for later treatment decisions.

Your nails are produced by cells that divide rapidly, which means chemotherapy affects them predictably. The changes can be dramatic and, for some women, more emotionally distressing than any other change because nails are so visible and so closely associated with self-presentation.

What is happening. The nail matrix — the tissue at the base of the nail that produces new nail cells — is damaged during each chemotherapy cycle. The damage shows up weeks later, because nails grow slowly. Ridges, horizontal lines (called Beau's lines), discoloration, darkening of the nail bed, lifting of the nail from the nail bed (onycholysis), and in more severe cases, loss of the nail entirely. Each cycle of chemotherapy produces a visible mark on the growing nail, which is why multi-cycle regimens often produce regular horizontal ridges or lines that correspond to each infusion. ⁷

Which drug categories cause it most. Taxanes (Scaffold Jammers) are notorious for nail changes, sometimes dramatic. Anthracyclines can cause darkening and lifting. Capecitabine and 5-FU can cause pigmentation changes at the nail bed.

What to do. Keep nails short. Avoid gel polish, shellac, and acrylics during treatment — the removal process can further damage already-compromised nails. Standard nail polish is generally fine and can actually help protect a compromised nail from minor trauma. Use cuticle oil daily to support the surrounding tissue. Consider cool-glove or cool-mitt therapy during infusion if your oncology team offers it — there is evidence that cooling the hands and feet during taxane infusions reduces nail toxicity, though the evidence is strongest for specific drugs and specific regimens. Ask your team.

When it is worth mentioning. Nail changes that are painful, rapidly progressive, or accompanied by signs of infection (redness, warmth, discharge) warrant prompt attention. Cosmetic nail changes without pain are expected and usually self-resolving.